Invitrogen™ SARS-CoV-2 Spike Protein S1 Recombinant Llama Monoclonal Antibody (RBD-2B9)

Catalog No.	Quantity
PIMA549334	100 μg

Catalog No. PIMA549334

Supplier: Invitrogen™ MA549334

Description

Llama Recombinant Monoclonal Antibody

SARS-CoV-2 Spike Protein S1 Recombinant Monoclonal Antibody for ELISA

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold symptoms to severe effects including death and respiratory distress. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain (Spike Protein). The Spike protein is the main surface antigen of the coronavirus. The glycosylated Spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. CoV diversity is reflected in the variable Spike proteins (S proteins), which have evolved into forms differing in their receptor interactions and their response to various environmental triggers of virus-cell membrane fusion.

Specifications

• Antigen: SARS-CoV-2 Spike Protein S1
• Applications: ELISA
• Classification: Recombinant Monoclonal
• Clone: RBD-2B9
• Conjugate: Unconjugated
• Formulation: PBS with no preservative
• Gene Alias: Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2
• Host Species: Llama
• Immunogen: SARS-CoV-2 S protein RBD containing C-terminal His Tag. The protein was expressed in human 293 cells (HEK293). It contains amino acids Arg 319-Lys 537.
• Purification Method: Affinity chromatography
• Quantity: 100 μg
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Target Species: Virus
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Product Type: Antibody
• Form: Liquid
• Isotype: scFv